The revised fourth edition of Evidence-Based Gastroenterology and Hepatology continues to provide the most current, evidence-based information for determining the appropriate medical and surgical options for screening for, diagnosing, and treating gastrointestinal conditions. With contributions from an international team of leading experts in the field, the 4th edition includes practical recommendations for the care of individual patients based on the latest scientific evidence.

CONTENTS:
Part I Gastrointestinal disorders
1 Gastroesophageal reflux disease
2 Barrett""s esophagus
3 Esophageal motility disorders
4 Eosinophilic esophagitis
5 Ulcer disease and Helicobacter pylori infection: current treatment
6 Nonsteroidal anti-inflammatory drug-gastropathy and enteropathy
7 Acute non-variceal gastrointestinal hemorrhage: treatment
8 Functional dyspepsia
9 Celiac disease: diagnosis, screening, and prognosis
10 Therapy for Crohn""s disease
11 Ulcerative colitis
12 Pouchitis after restorative proctocolectomy
13 Microscopic colitis: collagenous and lymphocytic colitis
14 Drug-induced diarrhea
15 Prevention and treatment of travelers"" diarrhea
16 Metabolic bone disease in gastrointestinal disorders
17 Colorectal cancer in ulcerative colitis: surveillance
18 Colorectal cancer: population screening and surveillance
19 Clostridium difficile infections: epidemiology, diagnosis, and treatment
20 Irritable bowel syndrome
21 Intestinal pseudo-obstruction (Ogilvie""s syndrome)
22 Gallstone disease
23 Acute pancreatitis
Part II Liver disease
24 Acute-on-chronic liver failure: diagnosis, prognosis, and treatment
25 Acute liver failure: prognosis and management
26 Infection in cirrhosis
27 Liver biopsy
28 Pregnancy and liver disease
29 Cholangiocarcinoma
30 Noninvasive tests of liver fibrosis
31 Hepatitis C: treatment
32 Hepatitis C virus (HCV) infection: in special situations
33 Hepatitis B: prognosis and treatment
34 Alcoholic liver disease
35 Nonalcoholic fatty liver disease
36 Hemochromatosis
37 Wilson""s disease
38 Primary biliary cholangitis (formerly primary biliary cirrhosis
39 Autoimmune hepatitis
40 Primary sclerosing cholangitis
41 Variceal bleeding
42 Hepatic venous outflow syndromes and splanchnic venous thrombosis
43 Ascites, hyponatremia, spontaneous bacterial peritonitis, and hepatorenal syndrome
44 Hepatic encephalopathy: classification, diagnosis, and treatment
45 Hepatocellular carcinoma: diagnosis and prognosis
46 Hepatocellular carcinoma: treatment
47 Drug-induced liver disease: mechanism and diagnosis
48 Liver transplantation: prevention and treatment of rejection
49 Liver transplantation: prevention and treatment of infection
50 Management of HCV infection after liver transplantation

Author:
John W.D. McDonald, Professor of Medicine, Robarts Clinical Trials, Western University, London, Ontario, Canada.
Brian G. Feagan, Professor of Medicine and Epidemiology and Biostatistics, Robarts Clinical Trials, Robarts Research Unit, Western University, London, Ontario, Canada.
Rajiv Jalan, Professor of Hepatology and Head, Liver Failure Group, University College London, London, UK.
Peter J. Kahrilas, Professor of Medicine, Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.